Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug
- 13 June 2005
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 26 (1), 47-53
- https://doi.org/10.1016/j.ejps.2005.04.018
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Effects of Formulation Variables and Post-compression Curing on Drug Release from a New Sustained-Release Matrix Material: Polyvinylacetate-PovidonePharmaceutical Development and Technology, 2001
- pH-independent release of a weakly basic drug from water-insoluble and -soluble matrix tabletsJournal of Controlled Release, 2000
- Selected advances in drug delivery and tissue engineeringJournal of Controlled Release, 1999
- Diffusion-controlled drug delivery systems: calculation of the required composition to achieve desired release profilesJournal of Controlled Release, 1999
- HPMC-Matrices for Controlled Drug Delivery: A New Model Combining Diffusion, Swelling, and Dissolution Mechanisms and Predicting the Release KineticsPharmaceutical Research, 1999
- Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug deliveryInternational Journal of Pharmaceutics, 1995
- Retardation of weakly basic drugs with diffusion tabletsInternational Journal of Pharmaceutics, 1990